Causal association between gut microbiome and polycystic ovary syndrome: A bidirectional Mendelian randomization study

Dongqin Xia(1), Linjie Xu(2), Xi Cheng(3), Chenglu Li(4), Siyi Chen(5), Yuquan Zhang(6),


(1) Department of Gynecology and Obstetrics, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, Jiangsu, China. Rugao Maternity Hospital, Rugao 226500, Jiangsu, China
(2) Department of Gynecology and Obstetrics, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, Jiangsu, China
(3) Department of Gynecology and Obstetrics, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, Jiangsu, China
(4) Department of Gynecology and Obstetrics, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, Jiangsu, China
(5) Department of Gynecology and Obstetrics, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, Jiangsu, China
(6) Department of Gynecology and Obstetrics, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, Jiangsu, China
Corresponding Author

Abstract


Through implementing a bidirectional Mendelian randomization (MR) study, the causal effects between gut microbiome and polycystic ovary syndrome (PCOS) were analyzed. Summary statistics for PCOS were acquired from the FinnGen consortium R8 release data, which included 27,943 cases and 162,936 controls. The inverse-variance weighting (IVW) method was adopted for analysis. Additionally, the causality involving exposure plus the outcome was evaluated by means of MR-Egger, weighted median, simple mode methods, as well as weighted mode. The IVW estimate showed that the genera Streptococcus plus Enterorhabdus served as protectors of PCOS. By contrast, the phylum Tenericutes, genera Anaerofilum, Coprococcus 2, Lachnospiraceae ND3007 group and Ruminiclostridium 5 were identified as risk elements of PCOS. Based on reverse MR analyses from PCOS on the intestinal microbiome based on the IVW method, the phyla Tenericutes, Actinobacteria, class Actinobacteria, genera Ruminococcaceae UCG004 and Christensenellaceae R 7group exhibited a down-regulation effect after PCOS onset. The genera Bacteroides, Barnesiella, Erysipelotrichaceae UCG003, Ruminococcus gnavus group, and Veillonella were up-regulated. No horizontal pleiotropy or significant IV heterogeneity was observed. We conclude that there is a causality relationship between gut microbiome and PCOS, where some bacterial taxa can be used as biomarkers to promote targeted diagnosis and therapy for PCOS.

References


Rao P and Bhide P. Controversies in the diagnosis of

polycystic ovary syndrome. Ther Adv Reprod Health.

; 14:2633494120913032.

Norman RJ, Dewailly D, Legro RS and Hickey TE. Polycystic

ovary syndrome. Lancet. 2007; 370(9588):685-97.

Butts SF, Seifer DB, Koelper N, Senapati S, Sammel MD,

Hoofnagle AN, Kelly A, Krawetz SA, Santoro N,

Zhang H, Diamond MP, Legro RS, Eunice Kennedy

Shriver National Institute of Child H and Human

Development Reproductive Medicine N. Vitamin D

Deficiency Is Associated With Poor Ovarian

Stimulation Outcome in PCOS but Not Unexplained

Infertility. J Clin Endocrinol Metab. 2019;

(2):369-378.

Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC,

Laven JS and Legro RS. Scientific Statement on the

Diagnostic Criteria, Epidemiology, Pathophysiology,

and Molecular Genetics of Polycystic Ovary

Syndrome. Endocr Rev. 2015; 36(5):487-525.

Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T,

Daniali M, Nikfar S, Tsatsakis A and Abdollahi M.

Polycystic Ovary Syndrome: A Comprehensive

Review of Pathogenesis, Management, and Drug

Repurposing. Int J Mol Sci. 2022; 23(2)

Damone AL, Joham AE, Loxton D, Earnest A, Teede HJ and

Moran LJ. Depression, anxiety and perceived stress in

women with and without PCOS: a community-based

study. Psychol Med. 2019; 49(9):1510-1520.

Jin P and Xie Y. Treatment strategies for women with

polycystic ovary syndrome. Gynecol Endocrinol.

; 34(4):272-277.

Vink JM, Sadrzadeh S, Lambalk CB and Boomsma DI.

Heritability of polycystic ovary syndrome in a Dutch

twin-family study. J Clin Endocrinol Metab. 2006;

(6):2100-4.

Abbott DH, Dumesic DA, Eisner JR, Colman RJ and Kemnitz

JW. Insights into the development of polycystic ovary

syndrome (PCOS) from studies of prenatally

androgenized female rhesus monkeys. Trends

Endocrinol Metab. 1998; 9(2):62-7.

Zhang J, Liu Y, Liu X, Xu L, Zhou L, Tang L, Zhuang J,

Guo W and Hu R. High Intake of Energy and Fat in

Southwest Chinese Women with PCOS: A

Population-Based Case-Control Study. PLoS One.

; 10(5):e0127094.

Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh

C, Nielsen T, Pons N, Levenez F, Yamada T, Mende

DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H,

Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto

JM, Hansen T, Le Paslier D, Linneberg A, Nielsen

HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner

K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang

X, Li S, Qin N, Yang H, Wang J, Brunak S, Dore J,

Guarner F, Kristiansen K, Pedersen O, Parkhill J,

Weissenbach J, Meta HITC, Bork P, Ehrlich SD and

Wang J. A human gut microbial gene catalogue

established by metagenomic sequencing. Nature.

; 464(7285):59-65.

Tremellen K and Pearce K. Dysbiosis of Gut Microbiota

(DOGMA)--a novel theory for the development of

Polycystic Ovarian Syndrome. Med Hypotheses.

; 79(1):104-12.

Sun MF and Shen YQ. Dysbiosis of gut microbiota and

microbial metabolites in Parkinson's Disease. Ageing

Res Rev. 2018; 45:53-61.

Jobira B, Frank DN, Pyle L, Silveira LJ, Kelsey MM,

Garcia-Reyes Y, Robertson CE, Ir D, Nadeau KJ and

Cree-Green M. Obese Adolescents With PCOS Have

Altered Biodiversity and Relative Abundance in

Gastrointestinal Microbiota. J Clin Endocrinol Metab.

; 105(6):e2134-44.

Li N, Li Y, Qian C, Liu Q, Cao W, Ma M, He R, Chen R,

Geng R and Liu Y. Dysbiosis of the Saliva

Microbiome in Patients With Polycystic Ovary

Syndrome. Front Cell Infect Microbiol. 2020;

:624504.

Kurilshikov A, Medina-Gomez C, Bacigalupe R,

Radjabzadeh D, Wang J, Demirkan A, Le Roy CI,

Raygoza Garay JA, Finnicum CT, Liu X, Zhernakova

DV, Bonder MJ, Hansen TH, Frost F, Ruhlemann MC,

Turpin W, Moon JY, Kim HN, Lull K, Barkan E, Shah

SA, Fornage M, Szopinska-Tokov J, Wallen ZD,

Borisevich D, Agreus L, Andreasson A, Bang C,

Bedrani L, Bell JT, Bisgaard H, Boehnke M,

Boomsma DI, Burk RD, Claringbould A, Croitoru K,

Davies GE, van Duijn CM, Duijts L, Falony G, Fu J,

van der Graaf A, Hansen T, Homuth G, Hughes DA,

Ijzerman RG, Jackson MA, Jaddoe VWV, Joossens

M, Jorgensen T, Keszthelyi D, Knight R, Laakso M,

Laudes M, Launer LJ, Lieb W, Lusis AJ, Masclee

AAM, Moll HA, Mujagic Z, Qibin Q, Rothschild D,

Shin H, Sorensen SJ, Steves CJ, Thorsen J, Timpson

NJ, Tito RY, Vieira-Silva S, Volker U, Volzke H,

Vosa U, Wade KH, Walter S, Watanabe K, Weiss S,

Weiss FU, Weissbrod O, Westra HJ, Willemsen G,

Payami H, Jonkers D, Arias Vasquez A, de Geus EJC,

Meyer KA, Stokholm J, Segal E, Org E, Wijmenga C,

Kim HL, Kaplan RC, Spector TD, Uitterlinden AG,

Rivadeneira F, Franke A, Lerch MM, Franke L, Sanna

S, D'Amato M, Pedersen O, Paterson AD, Kraaij R,

Raes J and Zhernakova A. Large-scale association

analyses identify host factors influencing human gut

microbiome composition. Nat Genet. 2021;

(2):156-165.

McAllister JM, Legro RS, Modi BP, Strauss JF and 3rd.

Functional genomics of PCOS: from GWAS to

molecular mechanisms. Trends Endocrinol Metab.

; 26(3):118-24.

Greenland S. An introduction to instrumental variables for

epidemiologists. Int J Epidemiol. 2000; 29(4): 722-

Burgess S and Thompson SG. Mendelian randomization :

methods for causal inference using genetic variants.

Second edition. ed. Chapman & Hall/CRC

interdisciplinary statistics series. CRC Press/Chapman

& Hall,Taylor and Francis Group; 2021.

Jia J, Dou P, Gao M, Kong X, Li C, Liu Z and Huang T.

Assessment of Causal Direction Between Gut

Microbiota-Dependent Metabolites and

Cardiometabolic Health: A Bidirectional Mendelian

Randomization Analysis. Diabetes. 2019; 68(9):1747-

Bowden J, Davey Smith G and Burgess S. Mendelian

randomization with invalid instruments: effect

estimation and bias detection through Egger

regression. Int J Epidemiol. 2015; 44(2):512-25.

FinnGen. FinnGen R8 release.

https://console.cloud.google.com/storage/browser/fin

ngen-public-datar8/summary_stats;tab=objects?prefix=&forceOnObje

ctsSortingFiltering=true

Sanna S, van Zuydam NR, Mahajan A, Kurilshikov A, Vich

Vila A, Vosa U, Mujagic Z, Masclee AAM, Jonkers

D, Oosting M, Joosten LAB, Netea MG, Franke L,

Zhernakova A, Fu J, Wijmenga C and McCarthy MI.

Causal relationships among the gut microbiome,

short-chain fatty acids and metabolic diseases. Nat

Genet. 2019; 51(4):600-605.

Li P, Wang H, Guo L, Gou X, Chen G, Lin D, Fan D, Guo

X and Liu Z. Association between gut microbiota and

preeclampsia-eclampsia: a two-sample Mendelian

randomization study. BMC Med. 2022; 20(1):443.

Burgess S, Butterworth A and Thompson SG. Mendelian

randomization analysis with multiple genetic variants

using summarized data. Genet Epidemiol. 2013;

(7):658-65.

Bowden J, Davey Smith G, Haycock PC and Burgess S.

Consistent Estimation in Mendelian Randomization

with Some Invalid Instruments Using a Weighted

Median Estimator. Genet Epidemiol. 2016; 40(4):304-

Hartwig FP, Davey Smith G and Bowden J. Robust inference

in summary data Mendelian randomization via the

zero modal pleiotropy assumption. Int J Epidemiol.

; 46(6):1985-1998.

Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V,

Baird D, Laurin C, Burgess S, Bowden J, Langdon R,

Tan VY, Yarmolinsky J, Shihab HA, Timpson NJ,

Evans DM, Relton C, Martin RM, Davey Smith G,

Gaunt TR and Haycock PC. The MR-Base platform

supports systematic causal inference across the human

phenome. Elife. 2018; 7

Bowden J and Holmes MV. Meta-analysis and Mendelian

randomization: A review. Res Synth Methods. 2019;

(4):486-496.

Lawlor DA, Harbord RM, Sterne JA, Timpson N and Davey

Smith G. Mendelian randomization: using genes as

instruments for making causal inferences in

epidemiology. Stat Med. 2008; 27(8):1133-63.

Verbanck M, Chen CY, Neale B and Do R. Detection of

widespread horizontal pleiotropy in causal

relationships inferred from Mendelian randomization

between complex traits and diseases. Nat Genet. 2018;

(5):693-698.

Zhang Y, Mao Q, Li Y, Cheng J, Xia Q, Chen G, Chen P,

Jin S, Li D, Zhong C, Yang J, Fan X, Liang Y and Lin

H. Cancer and COVID-19 Susceptibility and Severity:

A Two-Sample Mendelian Randomization and

Bioinformatic Analysis. Front Cell Dev Biol. 2021;

:759257.

Douglas Staiger JHS. Instrumental variables regression with

weak. 1994;

Hemani G, Tilling K and Davey Smith G. Orienting the

causal relationship between imprecisely measured

traits using GWAS summary data. PLoS Genet. 2017;

(11):e1007081.

Guo Y, Qi Y, Yang X, Zhao L, Wen S, Liu Y and Tang L.

Association between Polycystic Ovary Syndrome and

Gut Microbiota. PLoS One. 2016; 11(4):e0153196.

Kelley ST, Skarra DV, Rivera AJ and Thackray VG. The

Gut Microbiome Is Altered in a Letrozole-Induced

Mouse Model of Polycystic Ovary Syndrome. PLoS

One. 2016; 11(1):e0146509.

Torres PJ, Siakowska M, Banaszewska B, Pawelczyk L,

Duleba AJ, Kelley ST and Thackray VG. Gut

Microbial Diversity in Women With Polycystic Ovary

Syndrome Correlates With Hyperandrogenism. J Clin

Endocrinol Metab. 2018; 103(4):1502-1511.

Insenser M, Murri M, Del Campo R, Martinez-Garcia MA,

Fernandez-Duran E and Escobar-Morreale HF. Gut

Microbiota and the Polycystic Ovary Syndrome:

Influence of Sex, Sex Hormones, and Obesity. J Clin

Endocrinol Metab. 2018; 103(7):2552-2562.

Guo J, Shao J, Yang Y, Niu X, Liao J, Zhao Q, Wang D, Li

S and Hu J. Gut Microbiota in Patients with Polycystic

Ovary Syndrome: a Systematic Review. Reprod Sci.

; 29(1):69-83.

Zhou L, Ni Z, Cheng W, Yu J, Sun S, Zhai D, Yu C and Cai

Z. Characteristic gut microbiota and predicted

metabolic functions in women with PCOS. Endocr

Connect. 2020; 9(1):63-73.

Deng Y, Zhou M, Wang J, Yao J, Yu J, Liu W, Wu L, Wang

J and Gao R. Involvement of the microbiota-gut-brain

axis in chronic restraint stress: disturbances of the

kynurenine metabolic pathway in both the gut and

brain. Gut Microbes. 2021; 13(1):1-16.

Liang Y, Ming Q, Liang J, Zhang Y, Zhang H and Shen T.

Gut microbiota dysbiosis in polycystic ovary

syndrome: association with obesity - a preliminary

report. Can J Physiol Pharmacol. 2020; 98(11):803-

Liu R, Zhang C, Shi Y, Zhang F, Li L, Wang X, Ling Y, Fu

H, Dong W, Shen J, Reeves A, Greenberg AS, Zhao

L, Peng Y and Ding X. Dysbiosis of Gut Microbiota

Associated with Clinical Parameters in Polycystic

Ovary Syndrome. Front Microbiol. 2017; 8:324.

Dong S, Jiao J, Jia S, Li G, Zhang W, Yang K, Wang Z, Liu

C, Li D and Wang X. 16S rDNA Full-Length

Assembly Sequencing Technology Analysis of

Intestinal Microbiome in Polycystic Ovary Syndrome.

Front Cell Infect Microbiol. 2021; 11:634981.

Fu J, Bonder MJ, Cenit MC, Tigchelaar EF, Maatman A,

Dekens JA, Brandsma E, Marczynska J, Imhann F,

Weersma RK, Franke L, Poon TW, Xavier RJ, Gevers

D, Hofker MH, Wijmenga C and Zhernakova A. The

Gut Microbiome Contributes to a Substantial

Proportion of the Variation in Blood Lipids. Circ Res.

; 117(9):817-24.

Mancabelli L, Milani C, Lugli GA, Turroni F, Cocconi D,

van Sinderen D and Ventura M. Identification of

universal gut microbial biomarkers of common human

intestinal diseases by meta-analysis. FEMS Microbiol

Ecol. 2017; 93(12)

Waters JL and Ley RE. The human gut bacteria

Christensenellaceae are widespread, heritable, and

associated with health. BMC Biol. 2019; 17(1):83.

Chang CJ, Lin TL, Tsai YL, Wu TR, Lai WF, Lu CC and

Lai HC. Next generation probiotics in disease

amelioration. J Food Drug Anal. 2019; 27(3):615-622.

Zeng B, Lai Z, Sun L, Zhang Z, Yang J, Li Z, Lin J and

Zhang Z. Structural and functional profiles of the gut

microbial community in polycystic ovary syndrome

with insulin resistance (IR-PCOS): a pilot study. Res

Microbiol. 2019; 170(1):43-52.

Zhang J, Sun Z, Jiang S, Bai X, Ma C, Peng Q, Chen K,

Chang H, Fang T and Zhang H. Probiotic

Bifidobacterium lactis V9 Regulates the Secretion of

Sex Hormones in Polycystic Ovary Syndrome Patients

through the Gut-Brain Axis. mSystems. 2019; 4(2)

Grasset E, Puel A, Charpentier J, Collet X, Christensen JE,

Terce F and Burcelin R. A Specific Gut Microbiota

Dysbiosis of Type 2 Diabetic Mice Induces GLP-1

Resistance through an Enteric NO-Dependent and

Gut-Brain Axis Mechanism. Cell Metab. 2017;

(1):278.

Chavez-Carbajal A, Nirmalkar K, Perez-Lizaur A,

Hernandez-Quiroz F, Ramirez-Del-Alto S, GarciaMena J and Hernandez-Guerrero C. Gut Microbiota

and Predicted Metabolic Pathways in a Sample of

Mexican Women Affected by Obesity and Obesity

Plus Metabolic Syndrome. Int J Mol Sci. 2019; 20(2)

Mammadova G, Ozkul C, Yilmaz Isikhan S, Acikgoz A and

Yildiz BO. Characterization of gut microbiota in

polycystic ovary syndrome: Findings from a lean

population. Eur J Clin Invest. 2021; 51(4):e13417.

Hall AB, Yassour M, Sauk J, Garner A, Jiang X, Arthur T,

Lagoudas GK, Vatanen T, Fornelos N, Wilson R,

Bertha M, Cohen M, Garber J, Khalili H, Gevers D,

Ananthakrishnan AN, Kugathasan S, Lander ES,

Blainey P, Vlamakis H, Xavier RJ and Huttenhower

C. A novel Ruminococcus gnavus clade enriched in

inflammatory bowel disease patients. Genome Med.

; 9(1):103.

Zhou L, Ni Z, Yu J, Cheng W, Cai Z and Yu C. Correlation

Between Fecal Metabolomics and Gut Microbiota in

Obesity and Polycystic Ovary Syndrome. Front

Endocrinol (Lausanne). 2020; 11:628.

Tian Y, Zhang W, Zhao S, Sun Y, Bian Y, Chen T, Du Y,

Zhang J, Wang Z, Huang T, Peng Y, Yang P, Zhao H

and Chen ZJ. FADS1-FADS2 gene cluster confers

risk to polycystic ovary syndrome. Sci Rep. 2016;

:21195.

Khajeh M, Rahbarghazi R, Nouri M and Darabi M. Potential

role of polyunsaturated fatty acids, with particular

regard to the signaling pathways of arachidonic acid

and its derivatives in the process of maturation of the

oocytes: Contemporary review. Biomed

Pharmacother. 2017; 94:458-467.

Burgess S, Davies NM and Thompson SG. Bias due to

participant overlap in two-sample Mendelian

randomization. Genet Epidemiol. 2016; 40(7):597-


Full Text: PDF

Article Metrics

Abstract View : 1520 times
PDF Download : 317 times

Refbacks

  • There are currently no refbacks.